Jian Liu

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Top Venues

Drug design, development and therapy

Expert opinion on investigational drugs

BMC medical informatics and decision making

This page only lists publications with an associated author ORCID identifier.

Publications

Jian Liu, Qingwei Zhao, You Zhai, Xia Wu, Jiejing Kai, Jie Ruan, Minglan Wu, Meijia Wu, Zhuojun Zhou, Yuemei Yan, Jinzi J Wu, Yunqing Qiu
Safety, tolerability and pharmacokinetics of ASC10, a novel oral double prodrug of a broad-spectrum antiviral agent, β-d-N4-hydroxycytidine: results from a randomized, double-blind, placebo-controlled phase 1 study in Chinese healthy subjects. Expert opinion on investigational drugs 33 (8) (2024)
Jian Liu, Qingwei Zhao, You Zhai, Xia Wu, Jiejing Kai, Jie Ruan, Minglan Wu, Meijia Wu, Zhuojun Zhou, Yuemei Yan, Jinzi J Wu, Yunqing Qiu
Safety, tolerability and pharmacokinetics of ASC10, a novel oral double prodrug of a broad-spectrum antiviral agent, β-d-N4-hydroxycytidine: results from a randomized, double-blind, placebo-controlled phase 1 study in Chinese healthy subjects. Expert opinion on investigational drugs (2024)
Jian Liu, Qingwei Zhao, You Zhai, Xia Wu, Jiejing Kai, Jie Ruan, Minglan Wu, Meijia Wu, Zhuojun Zhou, Yuemei Yan, Jinzi J Wu, Yunqing Qiu
Safety, tolerability and pharmacokinetics of ASC10, a novel oral double prodrug of a broad-spectrum antiviral agent, β-d-N4-hydroxycytidine: results from a randomized, double-blind, placebo-controlled phase 1 study in Chinese healthy subjects. Expert opinion on investigational drugs 33 (8) (2024)
Jian Liu, Qingwei Zhao, You Zhai, Xia Wu, Jiejing Kai, Jie Ruan, Minglan Wu, Meijia Wu, Zhuojun Zhou, Yuemei Yan, Jinzi J Wu, Yunqing Qiu
Safety, tolerability and pharmacokinetics of ASC10, a novel oral double prodrug of a broad-spectrum antiviral agent, β-d-N4-hydroxycytidine: results from a randomized, double-blind, placebo-controlled phase 1 study in Chinese healthy subjects. Expert opinion on investigational drugs (2024)
Jian Liu, Minglan Wu, Jiejing Kai, Meihua Lin, Yunliang Zheng, Yiya Jiang, Qian Huang, You Zhai, Yunqing Qiu
Effect of Food on the Pharmacokinetics of Tenofovir Amibufenamide: A Phase I, Randomized, Open-Label, Two-Period Crossover Trial in Healthy Adult Subjects. Drug design, development and therapy 17 (2023)
Liang Shen, You Zhai, AXiang Pan, Qingwei Zhao, Min Zhou, Jian Liu
Development of an integrated and comprehensive clinical trial process management system. BMC medical informatics and decision making 23 (1) (2023)
Yujie Huang, You Zhai, Meijia Wu, Chengdong Chang, Jindan Luo, Dongsheng Hong, Qingwei Zhao, Yao Dai, Jian Liu
Targeting mTOR Complex 2 in Castration-Resistant Prostate Cancer with Acquired Docetaxel Resistance. Drug design, development and therapy 16 (2022)
You Zhai, Lihua Wu, Yunliang Zheng, Minglan Wu, Yujie Huang, Qian Huang, Jianzhong Shentu, Qingwei Zhao, Jian Liu
Bioequivalence Study of Amitriptyline Hydrochloride Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions. Drug design, development and therapy 14 (2020)
Jian Liu, You Zhai, Lihua Wu, Guolan Wu, Yunliang Zheng, Xingjiang Hu, Jianzhong Shentu
Pharmacokinetics and Tolerability of Single and Multiple Intravenous Doses of Cefotetan Disodium in Healthy Chinese Volunteers. Drug design, development and therapy 14 (2020)